Trapidil inhibits monocyte CD40 expression by preventing IFN-γ-induced STAT1 S727 phosphorylation

International Immunopharmacology

Volumn 4, Issue 7, 2004, Pages 863-871

  Zhou, Ling ^a   Schandené, Liliane ^a   Mordvinov, Viatcheslav A ^a   Chatelain, Pierre ^b   Pradier, Olivier ^a   Goldman, Michel ^a   Stordeur, Patrick ^a  

^a ERASME HOSPITAL   (Belgium)

^b UCB PHARMA   (Belgium)

Author keywords

CD40; IFN ; Serine phosphorylation; STAT1; Trapidil

Indexed keywords

AMINO ACID; CD40 ANTIGEN; DIMER; GAMMA INTERFERON; MESSENGER RNA; NUCLEAR RNA; SERINE; STAT1 PROTEIN; TRAPIDIL; TYROSINE;

ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; DIMERIZATION; DRUG EFFECT; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE PROBE; GENE REPRESSION; GENE TARGETING; HALF LIFE TIME; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MONOCYTE; NORMAL HUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA ANALYSIS; TRANSCRIPTION REGULATION;

ANTIGENS, CD40; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; MONOCYTES; PHOSPHORYLATION; RNA, MESSENGER; SERINE; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRAPIDIL;

EID: 2942545917     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.03.007     Document Type: Article

References (28)

1. Diehl L., Den Boer A.T., Van V.D., Melief C.J., Offringa R., et al. The role of CD40 in peripheral T cell tolerance and immunity. J. Mol. Med. 78:2000;363-371
2. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 67:2000;2-17
3. Laman J.D., de Smet B.J., Schoneveld A., van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol. Today. 18:1997;272-277
4. Noelle R.J., Mackey M., Foy T., Buhlmann J., Burns C. CD40 and its ligand in autoimmunity. Ann. N. Y. Acad. Sci. 815:1997;384-391
5. Pradier O., Willems F., Abramowicz D., Schandene L., de Boer M., et al. CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway. Eur. J. Immunol. 26:1996;3048-3054
6. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:1993;669-674
7. Nguyen V.T., Benveniste E.N. Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J. Biol. Chem. 275:2000;23674-23684
8. Leonard W.J. Role of Jak kinases and STATs in cytokine signal transduction. Int. J. Hematol. 73:2001;271-277
9. Ortmann R.A., Cheng T., Visconti R., Frucht D.M., O'Shea J.J. Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation. Arthritis Res. 2:2000;16-32
10. Bromberg J.F., Horvath C.M., Wen Z., Schreiber R.D., Darnell J.E.J. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7673-7678
11. Wen Z., Zhong Z., Darnell J.E.J. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250
12. Decker T., Kovarik P. Serine phosphorylation of STATs. Oncogene. 19:2000;2628-2637
13. Maresta A., Balducelli M., Cantini L., Casari A., Chioin R., et al. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. Circulation. 90:1994;2710-2715
14. Okamoto S., Inden M., Setsuda M., Konishi T., Nakano T. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am. Heart J. 123:1992;1439-1444
15. Zhou L., Ismaili J., Stordeur P., Thielemans K., Goldman M., et al. Inhibition of the CD40 pathway of monocyte activation by triazolopyrimidine. Clin. Immunol. 93:1999;232-238
16. Kumar A., Commane M., Flickinger T.W., Horvath C.M., Stark G.R. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science. 278:1997;1630-1632
17. Stordeur P., Poulin L.F., Craciun L., Zhou L., Schandene L., et al. Cytokine mRNA quantification by real-time PCR. J. Immunol. Methods. 259:2002;55-64
18. Osborn L., Kunkel S., Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2336-2340
19. Nguyen H., Ramana C.V., Bayes J., Stark G.R. Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J. Biol. Chem. 276:2001;33361-33368
20. Ouchi T., Lee S.W., Ouchi M., Aaronson S.A., Horvath C.M. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5208-5213
21. Zhang J.J., Zhao Y., Chait B.T., Lathem W.W., Ritzi M., et al. Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation. EMBO J. 17:1998;6963-6971
22. Kovarik P., Mangold M., Ramsauer K., Heidari H., Steinborn R., et al. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO. 20:2001;91-100
23. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12:1993;4221-4228
24. Kovarik P., Stoiber D., Eyers P.A., Menghini R., Neininger A., et al. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13956-13961
25. Takaoka A., Tanaka N., Mitani Y., Miyazaki T., Fujii H., et al. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-γ, but not IFN-α, signaling. EMBO J. 18:1999;2480-2488
26. Bonisch D., Weber A.A., Wittpoth M., Osinski M., Schror K. Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A. Mol. Pharmacol. 54:1998;241-248
27. Jaster R., Sparmann G., Emmrich J., Liebe S. Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut. 51:2002;579-584
28. Deb D.K., Sassano A., Lekmine F., Majchrzak B., Verma A., et al. Activation of protein kinase C delta by IFN-gamma. J. Immunol. 171:2003;267-273